Page last updated: 2024-08-22

platinum and Coronary Thrombosis

platinum has been researched along with Coronary Thrombosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allocco, DJ; Bouchard, A; Carrié, D; Dawkins, KD; Dens, J; Dubois, CL; Farah, B; Feldman, RL; Hagiwara, N; Kelly, CR; Meredith, IT; Pompili, V; Rabinowitz, A; Saito, S; Stone, GW; Teirstein, PS	1
Allocco, DJ; Christen, T; Crowley, J; Ferrario, M; Jung, W; Legrand, V; MacCarthy, P; Meredith, IT; Moreno, R; Redwood, S; Richardt, G; Schwimmbeck, P; Ungi, I; Werner, N; Zaman, A	1
Benito Gonzalez, T; de la Torre Hernandez, JM; Escaned, J; Garcia Del Blanco, B; Gomez Menchero, A; Gonzalo, N; Hernandez, F; Linares, JA; Moreno, R; Rivera, R; Subinas, A; Veiga Fernandez, G	1
Allocco, D; Aquino, M; Batchelor, W; Claessen, BE; Davis, S; Gigliotti, OS; Giugliano, G; Guedeney, P; Haghighat, A; Horwitz, PA; Kandzari, DE; Lopez, M; Mehran, R; Meredith, IT; Othman, I; Singh, S; Sorrentino, S; Tamis, L; Underwood, P; Wang, JC	1
Ando, K; Domei, T; Enomoto, S; Hiromasa, T; Hyodo, M; Iwabuchi, M; Kuramitsu, S; Mazaki, T; Shinozaki, T; Shirai, S; Soga, Y; Yamaji, K	1

Trials

1 trial(s) available for platinum and Coronary Thrombosis

Article	Year
Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial. JACC. Cardiovascular interventions, 2017, 12-11, Volume: 10, Issue:23 Topics: Aged; Asia; Cardiovascular Agents; Chromium Alloys; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Proportional Hazards Models; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome; United States	2017

Article

Year

Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.

JACC. Cardiovascular interventions, 2017, 12-11, Volume: 10, Issue:23

Topics: Aged; Asia; Cardiovascular Agents; Chromium Alloys; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Proportional Hazards Models; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome; United States

2017

Other Studies

4 other study(ies) available for platinum and Coronary Thrombosis

Article	Year
Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, 02-15, Volume: 93, Issue:3 Topics: Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Time Factors; Treatment Outcome	2019
The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry. Cardiovascular revascularization medicine : including molecular interventions, 2019, Volume: 20, Issue:8 Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Cardiovascular Agents; Chromium; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Recurrence; Registries; Retrospective Studies; Risk Factors; Spain; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome	2019
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, Jul-01, Volume: 94, Issue:1 Topics: Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Health Status Disparities; Humans; Male; Middle Aged; Minority Health; Myocardial Infarction; Observational Studies as Topic; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Race Factors; Registries; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; United States	2019
Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation. JACC. Cardiovascular interventions, 2015, Aug-17, Volume: 8, Issue:9 Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Risk Factors; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional	2015